[go: up one dir, main page]

BR9712298A - Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão - Google Patents

Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão

Info

Publication number
BR9712298A
BR9712298A BR9712298-0A BR9712298A BR9712298A BR 9712298 A BR9712298 A BR 9712298A BR 9712298 A BR9712298 A BR 9712298A BR 9712298 A BR9712298 A BR 9712298A
Authority
BR
Brazil
Prior art keywords
tuberculosis
polypeptide
expression vector
biological sample
recombinant expression
Prior art date
Application number
BR9712298-0A
Other languages
English (en)
Inventor
Steven G Reed
Yasir A W Skeiky
Davin C Dillon
Antonio Campos-Neto
Raymond Houghton
Thomas S Vedvivk
Daniel R Twardizk
Michael J Lodes
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/818,111 external-priority patent/US6338852B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of BR9712298A publication Critical patent/BR9712298A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"POLIPEPTìDEO, MOLéCULA DE DNA, VETOR DE EXPRESSãO RECOMBINANTE, CéLULA HOSPEDEIRA, PROCESSO PARA DETECTAR INFECçãO POR M. TUBERCULOSIS EM UMA AMOSTRA BIOLóGICA, KIT DIAGNóSTICO, ANTICORPOS MONOCLONAL, E, POLICLONAL, E, PROTEìNA DE FUSãO". Compostos e processos para diagnosticar tuberculose são descritos. Os compostos providos incluem polipeptídeos que contém pelo menos uma porção antigênica de uma ou mais proteínas de M. tuberculosis , e sequências de DNA codificando estes polipeptídeo s. Os kits diagnósticos contendo estes polipeptídeos ou sequências de DNA e um reagente de detecção apropriado podem ser usados para detecção de infecção por M. tuberculosis em pacientes e amostras biológicas. Os anticorpos dirigidos contra estes polipeptídeos são também providos.
BR9712298-0A 1996-10-11 1997-10-07 Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão BR9712298A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72962296A 1996-10-11 1996-10-11
US08/818,111 US6338852B1 (en) 1995-09-01 1997-03-13 Compounds and methods for diagnosis of tuberculosis
PCT/US1997/018214 WO1998016645A2 (en) 1996-10-11 1997-10-07 Compounds and methods for diagnosis of tuberculosis

Publications (1)

Publication Number Publication Date
BR9712298A true BR9712298A (pt) 2000-10-24

Family

ID=27111919

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712298-0A BR9712298A (pt) 1996-10-11 1997-10-07 Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão

Country Status (11)

Country Link
EP (1) EP0934415A2 (pt)
JP (1) JP2001500383A (pt)
AU (1) AU4750597A (pt)
BR (1) BR9712298A (pt)
CA (1) CA2268036A1 (pt)
CZ (1) CZ126699A3 (pt)
IL (2) IL129389A0 (pt)
NO (1) NO991693L (pt)
PL (1) PL333304A1 (pt)
TR (1) TR199901569T2 (pt)
WO (1) WO1998016645A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US7087713B2 (en) 2000-02-25 2006-08-08 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
CA2296419A1 (en) * 1997-07-16 1999-01-28 Institut Pasteur A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
AU773268B2 (en) * 1999-05-04 2004-05-20 Rutgers, The State University Of New Jersey Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines
US7009042B1 (en) 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
DE60033583T2 (de) * 1999-10-07 2007-09-13 Corixa Corp. CSC, Wilmington Eine mycobacterium tuberculosis kodierende sequenz zur expression von heterologen proteinen
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
EP2133100B1 (en) 2000-06-20 2011-10-05 Corixa Corporation MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof
AU2001271963A1 (en) * 2000-07-10 2002-01-21 Colorado State University Research Foundation Mid-life vaccine and methods for boosting anti-mycobacterial immunity
US7393539B2 (en) 2001-06-22 2008-07-01 Health Protection Agency Mycobacterial antigens expressed under low oxygen tension
AU2002314358C1 (en) 2001-07-04 2009-03-26 The Secretary Of State For Health Mycobacterial antigens expressed during latency
WO2003010309A1 (en) * 2001-07-25 2003-02-06 Tosoh Corporation Oligonucleotides for detecting tubercle bacillus and method therefor
GB0125535D0 (en) * 2001-10-24 2001-12-12 Microbiological Res Authority Mycobacterial genes down-regulated during latency
AU2003213118A1 (en) 2002-02-15 2003-09-09 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
WO2006053871A2 (en) 2004-11-16 2006-05-26 Crucell Holland B.V. Multivalent vaccines comprising recombinant viral vectors
ES2524572T3 (es) 2005-04-29 2014-12-10 Glaxosmithkline Biologicals S.A. Procedimiento novedoso de prevención o tratamiento de infección por M. tuberculosis
AU2006272567B2 (en) * 2005-07-26 2011-10-06 Rutgers, The State University Of New Jersey Antibody profiles characteristic of tuberculosis state
CN100999550B (zh) 2006-01-10 2010-10-06 中国人民解放军第三○九医院 结核分枝杆菌融合蛋白及其应用
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
WO2008140478A2 (en) 2006-11-01 2008-11-20 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens
HUE031184T2 (en) 2010-01-27 2017-06-28 Glaxosmithkline Biologicals Sa Modified tuberculosis antigens
CN115746092B (zh) * 2022-08-12 2024-08-13 齐鲁工业大学 具有抗氧化、抗衰老活性的钝顶螺旋藻藻蓝蛋白活性肽及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
EP0419355B1 (en) * 1989-09-19 2000-02-09 N.V. Innogenetics S.A. Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US5714593A (en) * 1995-02-01 1998-02-03 Institut Pasteur DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton protein
IL123506A (en) * 1995-09-01 2004-12-15 Corixa Corp Polypeptide compounds and preparations for immunotherapy and diagnosis of tuberculosis
CA2230927A1 (en) * 1995-09-01 1997-03-13 Corixa Corporation Compounds and methods for diagnosis of tuberculosis

Also Published As

Publication number Publication date
WO1998016645A3 (en) 1998-08-06
NO991693L (no) 1999-06-09
CA2268036A1 (en) 1998-04-23
IL121936A0 (en) 1998-03-10
NO991693D0 (no) 1999-04-09
TR199901569T2 (xx) 2000-12-21
WO1998016645A2 (en) 1998-04-23
AU4750597A (en) 1998-05-11
IL129389A0 (en) 2000-02-17
JP2001500383A (ja) 2001-01-16
CZ126699A3 (cs) 1999-09-15
PL333304A1 (en) 1999-11-22
EP0934415A2 (en) 1999-08-11

Similar Documents

Publication Publication Date Title
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
BR9908083A (pt) polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção de m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpo monoclonal, e, proteìna de fusão
Olins et al. The antigenic structure of the polypeptide chains of human γ-globulin
Fischer‐Colbrie et al. Isolation and immunological characterization of a glycoprotein from adrenal chromaffin granules
MX9801687A (es) Compuestos y metodos para el diagnostico de tuberculosis.
JPS60501179A (ja) ヒトｔ細胞白血病ウイルスの検出方法及び検出用物品
BR9712518A (pt) Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico
EP1104887A3 (en) A method and test kit for assaying collagen fragments in body fluids
BR9916020A (pt) Compostos e métodos para o tratamento e diagnóstico de infecção por chlamydia
GEP20012421B (en) Method for Typing Hepatitis C Virus and Reagents for Use Therein
KR910700459A (ko) 인슐린 의존성 진성당뇨병의 조기검진 및 치료를 위한 방법 및 조성물
AU3618095A (en) Alk-7 (activin like kinase), a serine threonine kinase receptor
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
BRPI0406265B8 (pt) método para análise por eletroforese capilar, método para pesquisa e tipagem de proteínas monoclonais, método de preparação de anticorpos modificados sobrecarregados negativamente e kit para detecção e tipagem de proteínas monoclonais
Zanders et al. Separation and characterization of a protein antigen from cells of Streptococcus mutans
KR910700463A (ko) 암과 관련된 헵토글로빈
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
Grey et al. The subunit structure of mouse IgA
AU638155B2 (en) Peptides with a characteristic antigenic determinant for alphal-microglobulin
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
EP0331514A3 (en) Assaying the duchenne muscular dystrophy protein deletion or defect
BR9910725A (pt) Indução de proteìnas e peptìdeos antibióticos por proteìnas lait/s cd14
FR2722508B1 (fr) Cassette d'expression d'une proteine p30 de toxoplasma gondii
Block et al. Indentity of a peritoneal fluid immunoglobulin light chain and the amyloid fibril i primary amyloidosis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]